Lipid–polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions

This publication has 97 references indexed in Scilit:

• Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging
  Chemical Communications, 2012
• Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
  Nano Letters, 2011
• In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
  Proceedings of the National Academy of Sciences, 2011
• Synthesis and Characterization of Lipid–Polymer Hybrid Nanoparticles with pH-Triggered Poly(ethylene glycol) Shedding
  Langmuir, 2011
• Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy
  Molecular Pharmaceutics, 2011
• Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
  Angewandte Chemie International Edition, 2011
• Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
  Proceedings of the National Academy of Sciences, 2011
• Half-Antibody Functionalized Lipid−Polymer Hybrid Nanoparticles for Targeted Drug Delivery to Carcinoembryonic Antigen Presenting Pancreatic Cancer Cells
  Molecular Pharmaceutics, 2010
• Spatiotemporal controlled delivery of nanoparticles to injured vasculature
  Proceedings of the National Academy of Sciences, 2010
• Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP
  Cancer Research, 2009